Intestinal Sensing Group, The University of Adelaide, Adelaide, SA 5005, Australia.
Adelaide Medical School, The University of Adelaide, Adelaide, SA 5005, Australia.
Nutrients. 2024 Oct 25;16(21):3628. doi: 10.3390/nu16213628.
High habitual consumption of non-nutritive sweeteners (NNS) is linked to increased incident type 2 diabetes, with emerging clinical evidence that effects on gut microbiota may, in part, drive this risk. However, the precise contribution of the effects of NNS on gut microbiota to host glycemic responses remains unclear. Ten-week-old male C57BL/6 mice (N = 10 per group) were randomized to drinking water with or without combined NNS (sucralose 1.5 mg/mL plus acesulfame-K 2.5 mg/mL) and with or without antibiotics to deplete gut microbiota (ABX, 1 mg/mL ampicillin and neomycin) over two weeks. Oral glucose tolerance tests (OGTT, 2 g/kg) were conducted on days -1 and 12. On day 14, mice underwent a jejunal infusion of glucose (300 mg) with 3-O-methyl glucose (30 mg, 3-OMG, a marker of glucose absorption) in 1.5 mL for 30 min, followed by blood collection and bioassays. Data were analyzed using ANOVA with NNS and ABX as factors. Jejunal glucose absorption was augmented in NNS+ mice relative to NNS- (31%; 3-OMG T30; ≤ 0.05) independent of ABX. ABX attenuated OGTT responses independent of NNS supplementation (-35%; incremental AUC, ≤ 0.001). NNS+ ABX+ mice had augmented GLP-1 responses to intrajejunal glucose relative to other groups (69-108%, < 0.05). These findings demonstrate that sub-acute NNS supplementation augments glucose absorption independent of gut microbiota in mice but does not disrupt glycemic responses. Antibiotic depletion of gut microbiota markedly increased glucose tolerance in mice, which may involve the actions of GLP-1.
高习惯性摄入非营养性甜味剂(NNS)与 2 型糖尿病的发生率增加有关,新出现的临床证据表明,肠道微生物组的影响可能部分导致这种风险。然而,NNS 对肠道微生物组影响宿主血糖反应的确切贡献仍不清楚。
10 周龄雄性 C57BL/6 小鼠(每组 10 只)随机分为饮用水组或含 NNS(三氯蔗糖 1.5 mg/mL 加乙酰磺胺酸钾 2.5 mg/mL)组,或含抗生素组(ABX,1 mg/mL 氨苄青霉素和新霉素)以在两周内耗尽肠道微生物组。在第-1 天和第 12 天进行口服葡萄糖耐量试验(OGTT,2 g/kg)。在第 14 天,小鼠接受了 30 min 的肠内葡萄糖输注(300 mg),同时输注 3-O-甲基葡萄糖(30 mg,3-OMG,葡萄糖吸收的标志物),随后采集血液并进行生物测定。数据分析采用方差分析,以 NNS 和 ABX 为因素。
与 NNS-组相比,NNS+组的肠内葡萄糖吸收增加(31%;3-OMG T30;≤0.05),与 ABX 无关。ABX 独立于 NNS 补充剂减弱 OGTT 反应(-35%;增量 AUC,≤0.001)。与其他组相比,NNS+ABX+组的肠内葡萄糖刺激 GLP-1 反应增加(69-108%;<0.05)。
这些发现表明,亚急性 NNS 补充剂在不依赖肠道微生物组的情况下增加了小鼠的葡萄糖吸收,但不会破坏血糖反应。肠道微生物组的抗生素耗竭显著增加了小鼠的葡萄糖耐量,这可能涉及 GLP-1 的作用。